All Updates

NASHVILLE, Tenn. – January 8, 2024 – With the 2024 legislative session set to begin Tuesday, here is a statement from Maddie Bushnell Michael, American Cancer Society Cancer Action Network (ACS CAN) Tennessee government relations director: “As Tennessee lawmakers dive into the 2024 legislative session, ACS CAN urges

ATLANTA, Ga. – January 5, 2024 – Statement from Julie Vojtech , American Cancer Society Cancer Action Network (ACS CAN) Georgia government relations director: “As Georgia lawmakers dive into the 2024 legislative session, ACS CAN urges them to prioritize legislation to ease the burden of cancer on Georgians. Georgia

The American Cancer Society Cancer Action Network (ACS CAN) announces two new members –– alongside newly-elected leadership officers to the Board of Directors, with terms that began on January 1, 2024. The Board provides leadership and guidance for ACS CAN, the advocacy affiliate of the American Cancer Society, which supports evidence-based policy and legislative solutions designed to end cancer as we know it, for everyone.

Today, the U.S. Court of Appeals for the Second Circuit will hear oral arguments in the case of Haller v. Health and Human Services (HHS) and decide whether or not to uphold the U.S. District Court’s ruling preserving the No Surprises Act (NSA), legislation that prohibits patients from receiving surprise bills for unexpected out-of-network costs.

Today, the U.S. Court of Appeals for the Second Circuit will hear oral arguments in the case of Haller v. Health and Human Services (HHS) and decide whether or not to uphold the U.S. District Court’s ruling preserving the No Surprises Act (NSA), legislation that prohibits patients from receiving surprise bills for unexpected out-of-network costs.

ALBANY, NY – DECEMBER 22, 2023 – Today, Governor Kathy Hochul signed Senate Bill 1196a / Assembly Bill 1673a into law, securing a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable

ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support